Alteration of the Fatty Acid Metabolism in the Rat Kidney Caused by the Injection of Serum from Patients with Collapsing Glomerulopathy

Patients with collapsing glomerulopathy (CG) have marked proteinuria that rapidly progresses to chronic renal failure. In this study, we investigated if the nephropathy produced in a rat model by the injection of serum from CG patients induced alterations in fatty acid (FA) metabolism. Twenty-four f...

Full description

Bibliographic Details
Main Authors: Elizabeth Soria-Castro, Verónica Guarner-Lans, María Elena Soto, María del Carmen Avila-Casado, Linaloe Manzano Pech, Israel Pérez-Torres
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/8/10/388
_version_ 1797552316757311488
author Elizabeth Soria-Castro
Verónica Guarner-Lans
María Elena Soto
María del Carmen Avila-Casado
Linaloe Manzano Pech
Israel Pérez-Torres
author_facet Elizabeth Soria-Castro
Verónica Guarner-Lans
María Elena Soto
María del Carmen Avila-Casado
Linaloe Manzano Pech
Israel Pérez-Torres
author_sort Elizabeth Soria-Castro
collection DOAJ
description Patients with collapsing glomerulopathy (CG) have marked proteinuria that rapidly progresses to chronic renal failure. In this study, we investigated if the nephropathy produced in a rat model by the injection of serum from CG patients induced alterations in fatty acid (FA) metabolism. Twenty-four female Sprague-Dawley rats were divided into four groups of six rats each: Group I, control rats (C); Group II, rats that received injections of 1 mL of 0.9% NaCl saline solution (SS); Group III, rats injected with 25 mg/mL of serum from healthy subjects (HS); and Group IV, rats injected with 25 mg/mL of serum from CG patients. In all groups, the systolic blood pressure (SBP), proteinuria, creatinine clearance (CC), cholesterol and total FA composition in the kidney and serum were evaluated. The administration of serum from CG patients to rats induced glomerular collapse, proteinuria, reduced CC and elevated SBP (<i>p</i> ≤ 0.01) in comparison with the C, SS and HS rats. The FA composition of the serum of rats that received the CG serum showed an increase in palmitic acid (PA) and a decrease in arachidonic acid (AA) when compared to serum from HS (<i>p</i> ≤ 0.02). In rats receiving the CG serum, there was also a decrease in the AA in the kidney but there was an increase in the PA in the serum and kidney (<i>p</i> ≤ 0.01). These results suggest that the administration of serum from CG patients to rats induces alterations in FA metabolism including changes in PA and in AA, which are precursors for the biosynthesis of the prostaglandins that are involved in the elevation of SBP and in renal injury. These changes may contribute to collapsing glomerulopathy disease.
first_indexed 2024-03-10T15:59:15Z
format Article
id doaj.art-df62a22f594448fb8f3eb83fe82c21ac
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T15:59:15Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-df62a22f594448fb8f3eb83fe82c21ac2023-11-20T15:28:50ZengMDPI AGBiomedicines2227-90592020-09-0181038810.3390/biomedicines8100388Alteration of the Fatty Acid Metabolism in the Rat Kidney Caused by the Injection of Serum from Patients with Collapsing GlomerulopathyElizabeth Soria-Castro0Verónica Guarner-Lans1María Elena Soto2María del Carmen Avila-Casado3Linaloe Manzano Pech4Israel Pérez-Torres5Cardiovascular Biomedicine, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Col. Sección XVI, Mexico City 14080, MexicoPhysiology Department, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, Mexico City 14080, MexicoImmunology Department, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, Mexico City 14080, MexicoPathology Department, University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON M5G 2C4, CanadaCardiovascular Biomedicine, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Col. Sección XVI, Mexico City 14080, MexicoCardiovascular Biomedicine, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Col. Sección XVI, Mexico City 14080, MexicoPatients with collapsing glomerulopathy (CG) have marked proteinuria that rapidly progresses to chronic renal failure. In this study, we investigated if the nephropathy produced in a rat model by the injection of serum from CG patients induced alterations in fatty acid (FA) metabolism. Twenty-four female Sprague-Dawley rats were divided into four groups of six rats each: Group I, control rats (C); Group II, rats that received injections of 1 mL of 0.9% NaCl saline solution (SS); Group III, rats injected with 25 mg/mL of serum from healthy subjects (HS); and Group IV, rats injected with 25 mg/mL of serum from CG patients. In all groups, the systolic blood pressure (SBP), proteinuria, creatinine clearance (CC), cholesterol and total FA composition in the kidney and serum were evaluated. The administration of serum from CG patients to rats induced glomerular collapse, proteinuria, reduced CC and elevated SBP (<i>p</i> ≤ 0.01) in comparison with the C, SS and HS rats. The FA composition of the serum of rats that received the CG serum showed an increase in palmitic acid (PA) and a decrease in arachidonic acid (AA) when compared to serum from HS (<i>p</i> ≤ 0.02). In rats receiving the CG serum, there was also a decrease in the AA in the kidney but there was an increase in the PA in the serum and kidney (<i>p</i> ≤ 0.01). These results suggest that the administration of serum from CG patients to rats induces alterations in FA metabolism including changes in PA and in AA, which are precursors for the biosynthesis of the prostaglandins that are involved in the elevation of SBP and in renal injury. These changes may contribute to collapsing glomerulopathy disease.https://www.mdpi.com/2227-9059/8/10/388collapsing glomerulopathysystolic blood pressurefatty acidsproteinuria
spellingShingle Elizabeth Soria-Castro
Verónica Guarner-Lans
María Elena Soto
María del Carmen Avila-Casado
Linaloe Manzano Pech
Israel Pérez-Torres
Alteration of the Fatty Acid Metabolism in the Rat Kidney Caused by the Injection of Serum from Patients with Collapsing Glomerulopathy
Biomedicines
collapsing glomerulopathy
systolic blood pressure
fatty acids
proteinuria
title Alteration of the Fatty Acid Metabolism in the Rat Kidney Caused by the Injection of Serum from Patients with Collapsing Glomerulopathy
title_full Alteration of the Fatty Acid Metabolism in the Rat Kidney Caused by the Injection of Serum from Patients with Collapsing Glomerulopathy
title_fullStr Alteration of the Fatty Acid Metabolism in the Rat Kidney Caused by the Injection of Serum from Patients with Collapsing Glomerulopathy
title_full_unstemmed Alteration of the Fatty Acid Metabolism in the Rat Kidney Caused by the Injection of Serum from Patients with Collapsing Glomerulopathy
title_short Alteration of the Fatty Acid Metabolism in the Rat Kidney Caused by the Injection of Serum from Patients with Collapsing Glomerulopathy
title_sort alteration of the fatty acid metabolism in the rat kidney caused by the injection of serum from patients with collapsing glomerulopathy
topic collapsing glomerulopathy
systolic blood pressure
fatty acids
proteinuria
url https://www.mdpi.com/2227-9059/8/10/388
work_keys_str_mv AT elizabethsoriacastro alterationofthefattyacidmetabolismintheratkidneycausedbytheinjectionofserumfrompatientswithcollapsingglomerulopathy
AT veronicaguarnerlans alterationofthefattyacidmetabolismintheratkidneycausedbytheinjectionofserumfrompatientswithcollapsingglomerulopathy
AT mariaelenasoto alterationofthefattyacidmetabolismintheratkidneycausedbytheinjectionofserumfrompatientswithcollapsingglomerulopathy
AT mariadelcarmenavilacasado alterationofthefattyacidmetabolismintheratkidneycausedbytheinjectionofserumfrompatientswithcollapsingglomerulopathy
AT linaloemanzanopech alterationofthefattyacidmetabolismintheratkidneycausedbytheinjectionofserumfrompatientswithcollapsingglomerulopathy
AT israelpereztorres alterationofthefattyacidmetabolismintheratkidneycausedbytheinjectionofserumfrompatientswithcollapsingglomerulopathy